Product image of Levetiracetam Hormosan (Levetiracetam) supplied by GNH India

Levetiracetam Hormosan

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Hormosan (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Hormosan, is an anticonvulsant presented as an oral tablet for systemic administration. It is used to control partial, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy, helping to reduce seizure frequency and improve quality of life.

GNH India supplies Levetiracetam Hormosan as a licensed, Good Distribution Practice‑compliant pharmaceutical product, providing reliable global sourcing for hospitals, pharmacies and clinics. The company follows stringent quality standards and offers regulatory‑approved documentation to support international procurement and patient care.

Manufacturer / TM Owner

Hormosan Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic drug that reduces neuronal excitability in seizure disorders.
  • Partial seizures: decreases frequency of focal onset seizures in adults and children.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with primary generalized epilepsy.
  • Myoclonic seizures: reduces rapid jerking movements associated with juvenile myoclonic epilepsy.
  • Adjunct therapy: used as add‑on treatment when seizures are not adequately controlled by other agents.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces the synchronization of neuronal firing, thereby lowering the likelihood of seizure propagation. The precise downstream effects involve inhibition of calcium‑dependent exocytosis and attenuation of excitatory pathways, contributing to its broad antiepileptic activity across multiple seizure types.

Side Effects

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Dizziness
  • Somnolence
  • Fatigue
  • Irritability
  • Headache
  • Nausea

Serious or Rare Side Effects

  • Severe allergic reactions such as Stevens‑Johnson syndrome
  • Psychiatric disturbances including aggression, depression, or suicidal thoughts
  • Rash or multi‑organ hypersensitivity
  • Blood dyscrasias such as leukopenia or thrombocytopenia

Precautions & Warnings

  • Levetiracetam requires careful monitoring in several clinical situations.
  • Renal impairment: dose adjustment may be required in patients with reduced kidney function.
  • Hepatic dysfunction: monitor liver enzymes in patients with liver disease.
  • Psychiatric history: observe for mood changes or behavioral disturbances.
  • Concomitant CNS depressants: use caution as additive sedation may occur.
  • Pregnancy and lactation: risk unknown; weigh benefits against potential risks.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy.
  • Phenytoin: may increase risk of neurotoxicity when combined.
  • Phenobarbital: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive CNS depression may occur.
  • Other antiepileptics (valproate, lamotrigine): monitor seizure control.
  • Renal excretion inhibitors (cimetidine): may increase levetiracetam exposure.

Frequently Asked Questions

Levetiracetam Hormosan is prescribed to treat epilepsy by reducing the frequency of partial, generalized tonic‑clonic and myoclonic seizures. It is used in both adult and pediatric patients when seizure control is required.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilises neuronal membranes and diminishes the synchronisation of neuronal firing, thereby lowering the chance of seizure propagation.

The appropriate dose is determined by the prescribing clinician based on the patient’s age, weight, renal function and seizure type. Dosage adjustments are made individually; no standard regimen is provided here.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians must weigh the potential benefits of seizure control against any possible risks to the fetus or infant, and discuss options with the patient.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a favourable side‑effect profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen when a broad‑spectrum agent is needed, but individual response and tolerability guide final selection.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not refrigerate or freeze the product.

Levetiracetam Hormosan is taken orally, usually as a tablet swallowed whole with water. It can be taken with or without food, according to the prescribing information provided by the healthcare professional.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, psychiatric changes like aggression, depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if any of these symptoms appear.

Patients with a known hypersensitivity to levetiracetam or any of its excipients should avoid the drug. Those with severe renal impairment require careful dose adjustment, and clinicians may consider alternative therapy if appropriate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT